In One Timeline

The Price of Insulin (1923-2024)

The discoverers sold the insulin patent for $1 'so it would belong to the world.' A century later the list price of a flagship analog had climbed ~13x to almost $300 a vial - until 2022-23 caps and ~70% maker cuts snapped it back near $66. Plotted on one linear curve: the gift, the climb, the hidden rebate gap, and the cap.

credits6sourcesAll episodes
No third-party image credits. This episode's visuals are original charts/animations and AI-generated b-roll — nothing that requires attribution.

Data sources & references

01USC Schaeffer Center — Untangling the Price of Insulin
02AJMC — insulin list vs net price studies
03Eli Lilly — newsroom pricing disclosures (2023 list-price cuts)
04U.S. Senate Finance Committee — 2021 insulin report
05KFF — IRA Medicare insulin cap
06U.S. Bureau of Labor Statistics — CPI-U (inflation adjustment)